Trial Profile
A Single-Dose, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of LY3053102 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jul 2018
Price :
$35
*
At a glance
- Drugs LY 3053102 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Eli Lilly and Company
- 16 Jun 2014 New trial record